UNCY•benzinga•
Unicycive Therapeutics Stock Is Trading Lower Tuesday: What's Going On?
Summary
Unicycive announced update on its NDA for oxylanthanum carbonate to treat hyperphosphatemia in patients with chronic kidney disease on dialysis.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on June 10, 2025 by benzinga